National Heart, Lung, and Blood Institute Launches Biomarker Consortium to Combat Cardiovascular Disease

Summary

The National Heart, Lung, and Blood Institute (NHLBI) is collaborating with partners to develop novel biomarkers for cardiovascular disease and related risk factors, aiming to create new diagnostic tests to identify individuals at high risk and potentially discover new therapeutic targets.